Oncopeptides AB sell mixitrader
Start price
12.11.22
/
50%
€1.96
Target price
12.11.23
€0.000
Performance (%)
-17.89%
End price
26.11.22
€1.61
Summary
This prediction ended on 26.11.22 with a price of €1.61. The price of Oncopeptides AB decreased from the start of the prediction. Compared to the start price this resulted in a performance of -17.89%. mixitrader has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oncopeptides AB | -26.385% | -26.385% | -72.809% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to mixitrader what are the pros and cons of Oncopeptides AB for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
Below average Marketposition
high free float
Business model of the past or high risk
Higher risks for its business
Significant cyclical dependencies
Little known brand
Comments by mixitrader for this prediction
In the thread Oncopeptides AB diskutieren
Sell mit Kursziel 0,0
In the thread Trading Oncopeptides AB
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.